BDTX
Black Diamond Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.12
+0.95%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- $8.3M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.20
- Revenue actual
- —
- Revenue estimate
- $5.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +19.4%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026